[144] EXACT SCIENCES CORP SEC Filing

Rhea-AI Filing Summary

Exact Sciences (EXAS) filing a Form 144 notifies a proposed sale of 2,000 common shares held by an insider through Fidelity Brokerage Services LLC with an aggregate market value of $120,000.00. The shares represent part of outstanding common stock of 189,319,110 shares and the planned approximate sale date is 10/09/2025 on NASDAQ. The filer reports the shares were acquired on 03/17/2022 via a stock option exercise and paid in cash.

The filing also discloses a sale of 1,485 shares on 08/13/2025 that generated gross proceeds of $62,399.70. The notice includes the standard representation that the seller does not possess undisclosed material adverse information and references Rule 10b5-1 timing language if applicable.

Insights

Corporate Insider Transactions Analyst

Insider intends to sell a small block of 2,000 EXAS shares; prior small sale on 08/13/2025 noted.

The filing shows the insider acquired the shares by stock option exercise on 03/17/2022 and plans to sell 2,000 shares via Fidelity with an indicated aggregate market value of $120,000.00 and a planned sale date of 10/09/2025. A prior disposition of 1,485 shares on 08/13/2025 produced $62,399.70 in gross proceeds.

The transaction size is small relative to total shares outstanding (189,319,110), reducing direct market impact; primary dependency is timely execution on 10/09/2025. Monitor filings for any additional insider sales or a Rule 10b5-1 adoption date if provided, which would clarify whether sales follow a pre-established plan.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2000	120000.00	189319110	10/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/17/2022	Stock Option Exercise	Issuer			2000	03/17/2022	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James Doyle 5505 Endeavor Lane Madison WI 53719	Common	08/13/2025	1485	62399.70

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What transaction does Exact Sciences (EXAS) report on Form 144?

The filing notifies a proposed sale of 2,000 common shares acquired by stock option exercise on 03/17/2022, to be sold around 10/09/2025.

What is the aggregate market value of the shares proposed for sale in the EXAS Form 144?

The aggregate market value reported is $120,000.00 for the 2,000 shares.

How many EXAS shares were sold recently by the same person and what were the proceeds?

The filer sold 1,485 shares on 08/13/2025, generating gross proceeds of $62,399.70.

Through which broker will the EXAS shares be sold?

The notice lists Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI as the broker handling the proposed sale.

What statement does the seller make about material nonpublic information?

By signing, the seller represents they do not know any material adverse information about the issuer that has not been publicly disclosed.